UA7080A1 - Спосіб одержання кристалічного торасеміду - Google Patents

Спосіб одержання кристалічного торасеміду

Info

Publication number
UA7080A1
UA7080A1 UA4027953A UA4027953A UA7080A1 UA 7080 A1 UA7080 A1 UA 7080A1 UA 4027953 A UA4027953 A UA 4027953A UA 4027953 A UA4027953 A UA 4027953A UA 7080 A1 UA7080 A1 UA 7080A1
Authority
UA
Ukraine
Prior art keywords
thoracemide
modification
producing crystalline
space group
melting temperature
Prior art date
Application number
UA4027953A
Other languages
English (en)
Russian (ru)
Inventor
Топфмайєр Фрітц
Леттенбауер Густав
Original Assignee
"Берінгер Манхайм Гмбх
Берингер Манхайм Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Берінгер Манхайм Гмбх, Берингер Манхайм Гмбх filed Critical "Берінгер Манхайм Гмбх
Publication of UA7080A1 publication Critical patent/UA7080A1/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Заявлено спосіб одержання кристалічного торасеміду в хімічно чистій модифікації I, що кристалізується моноклінно в просторовій групі Р21/c з температурою плавлення 169°С. Торасемід у вигляді модифікації II, що кристалізується моноклінно в просторовій групі P21/n з температурою плавлення 162°С з домішкою модифікації І суспендують у воді з додаванням каталітичної кількості хімічно чистого торасеміду модифікації I при температурі від кімнатної до 90°С і часу від 6 год. до 8 днів з подальшим охолоджуванням суміші і сепаруванням цільового продукту.
UA4027953A 1985-08-17 1986-08-15 Спосіб одержання кристалічного торасеміду UA7080A1 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853529529 DE3529529A1 (de) 1985-08-17 1985-08-17 Verfahren zur herstellung einer stabilen modifikation von torasemid

Publications (1)

Publication Number Publication Date
UA7080A1 true UA7080A1 (uk) 1995-06-30

Family

ID=6278766

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4027953A UA7080A1 (uk) 1985-08-17 1986-08-15 Спосіб одержання кристалічного торасеміду

Country Status (25)

Country Link
US (4) US4743693A (uk)
EP (1) EP0212537B1 (uk)
JP (2) JPS6245576A (uk)
KR (1) KR930009818B1 (uk)
AU (1) AU573454B2 (uk)
CA (1) CA1307277C (uk)
CS (2) CS259891B2 (uk)
DD (1) DD259858A5 (uk)
DE (2) DE3529529A1 (uk)
DK (1) DK162518C (uk)
ES (1) ES2001522A6 (uk)
FI (1) FI82189C (uk)
GR (1) GR862139B (uk)
HK (1) HK59994A (uk)
HU (1) HU195778B (uk)
IE (1) IE59237B1 (uk)
IL (1) IL79672A (uk)
LT (1) LT3596B (uk)
NO (1) NO170079C (uk)
NZ (1) NZ217172A (uk)
PL (1) PL146086B1 (uk)
PT (1) PT83186B (uk)
SU (1) SU1480766A3 (uk)
UA (1) UA7080A1 (uk)
ZA (1) ZA866151B (uk)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623620A1 (de) * 1986-07-12 1988-01-21 Boehringer Mannheim Gmbh Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung
US5166162A (en) * 1990-03-02 1992-11-24 Adir Et Compagnie Pyridylsulfonylurea and pyridylsulfonylthiourea compounds
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
HRP980532B1 (en) * 1998-10-02 2005-06-30 Pliva Novel crystalline torasemide modification
US5914336A (en) 1998-06-02 1999-06-22 Boehringer Mannheim Gmbh Method of controlling the serum solubility of orally administered torasemide and composition relating thereto
US6166045A (en) 1998-06-02 2000-12-26 Roche Diagnostics Gmbh Torasemide of modification III
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
CZ2002404A3 (cs) 1999-08-11 2002-06-12 Teva Pharmaceutical Industries Ltd. Polymorfní formy torsemidu
DE1292303T1 (de) 2000-02-17 2003-09-18 Teva Pharma Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
US6635765B2 (en) 2000-03-20 2003-10-21 Teva Pharmaceutical Industries, Ltd. Processes for preparing torsemide intermediate
HRP20000162B1 (en) * 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
HRP20000765A2 (en) * 2000-11-10 2002-06-30 Pliva D D Compositions of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides with increased release
US20030022921A1 (en) * 2001-02-21 2003-01-30 Minutza Leibovici Stable pharmaceutical formulation comprising torsemide modification II
IN192178B (uk) * 2001-08-03 2004-03-06 Ranbaxy Lab
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
ITMI20020639A1 (it) * 2002-03-27 2003-09-29 Cosma S P A Composizioni farmaceutiche comprendenti come principio attivo 1-isopropil-3°(4-m-toluidino-3-pridil)sulfonil!-urea
HRP20020603B1 (en) * 2002-07-19 2008-11-30 Pliva D.D. New process for the preparation of modification i n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide
PT1465890E (pt) * 2002-11-18 2007-05-31 Teva Pharma Lansoprazole estável contendo mais de 500 ppm, até cerca de 3000 ppm de água e mais de 200 ppm, até cerca de 5000 de álcool
US7678816B2 (en) * 2003-02-05 2010-03-16 Teva Pharmaceutical Industries Ltd. Method of stabilizing lansoprazole
ES2244324B1 (es) * 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
AT500576B1 (de) * 2004-07-28 2006-11-15 Sanochemia Pharmazeutika Ag Verfahren zur reindarstellung von kristallformen von torsemid
US10178893B1 (en) * 2013-06-14 2019-01-15 Scott Bradley Baker Shoe
FR3018688A1 (fr) * 2014-03-19 2015-09-25 Virbac Utilisation de torasemide a faible dose dans une composition veterinaire
EP3031471A1 (en) 2014-12-12 2016-06-15 Ceva Sante Animale Veterinary composition for the treatment of pulmonary edema associated with heart failure in domestic animals
US12048677B2 (en) 2014-12-12 2024-07-30 Ceva Sante Animale Compositions and uses thereof for the treatment of heart failure in domestic animals
DK3173075T3 (en) * 2015-11-27 2019-01-21 Accupharma Spolka Z Ograniczona Odpowiedzialnoscia PHARMACEUTICAL COMBINATION PREPARATION OF ACE INHIBITOR AND LOOPDIURETIC
CN115417810B (zh) * 2022-09-22 2023-10-10 南京正科医药股份有限公司 一种托拉塞米晶型ⅰ的精制方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US30633A (en) * 1860-11-13 Improvement in fire-escapes
GB1477664A (en) * 1974-04-17 1977-06-22 Christiaens Sa A Pyridine derivatives
GB1593609A (en) * 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
LU85193A1 (fr) * 1984-01-31 1985-09-12 Christiaens Sa A Nouveaux derives de la 4-phenylaminopyridine,leur utilisation et leur preparation

Also Published As

Publication number Publication date
CS594586A2 (en) 1988-03-15
NO170079C (no) 1992-09-09
DK385586A (da) 1987-02-18
NZ217172A (en) 1989-02-24
NO863305D0 (no) 1986-08-15
SU1480766A3 (ru) 1989-05-15
KR930009818B1 (ko) 1993-10-11
CS259891B2 (en) 1988-11-15
HK59994A (en) 1994-07-08
LTIP898A (en) 1995-03-27
DK385586D0 (da) 1986-08-13
DE3529529A1 (de) 1987-02-19
USRE34580E (en) 1994-04-05
US4822807A (en) 1989-04-18
DE3529529C2 (uk) 1987-05-27
LT3596B (en) 1995-12-27
JPH0415205B2 (uk) 1992-03-17
US4743693A (en) 1988-05-10
NO170079B (no) 1992-06-01
AU573454B2 (en) 1988-06-09
PL261052A1 (en) 1987-11-02
IE862179L (en) 1987-02-17
HU195778B (en) 1988-07-28
FI82189C (fi) 1991-02-11
DK162518B (da) 1991-11-11
AU6105586A (en) 1987-02-19
PT83186A (de) 1986-09-01
JPH02191255A (ja) 1990-07-27
EP0212537A1 (de) 1987-03-04
CS419991A3 (en) 1992-06-17
PL146086B1 (en) 1988-12-31
GR862139B (en) 1986-12-30
ZA866151B (en) 1987-04-29
EP0212537B1 (de) 1990-01-03
DD259858A5 (de) 1988-09-07
IL79672A0 (en) 1986-11-30
FI863305A (fi) 1987-02-18
ES2001522A6 (es) 1988-06-01
IE59237B1 (en) 1994-01-26
DK162518C (da) 1992-03-30
FI863305A0 (fi) 1986-08-15
FI82189B (fi) 1990-10-31
JPS6245576A (ja) 1987-02-27
DE3667970D1 (de) 1990-02-08
JPH0643400B2 (ja) 1994-06-08
NO863305L (no) 1987-02-18
HUT42069A (en) 1987-06-29
USRE34672E (en) 1994-07-26
CA1307277C (en) 1992-09-08
PT83186B (pt) 1988-07-01
KR870002076A (ko) 1987-03-30
IL79672A (en) 1990-01-18

Similar Documents

Publication Publication Date Title
UA7080A1 (uk) Спосіб одержання кристалічного торасеміду
DE3751478D1 (de) Herstellungsverfahren einer viskositätsstabilen antisäurezusammensetzung.
MX9703879A (es) Preparacion de suspension de cristales de hielo en una solucion de azucar y su uso para hacer confecciones.
KR890016014A (ko) 고순도 카프로락탐의 제조방법
CA1250832A (en) PREPARATION OF 2-OXINDOLE-1-CARBOXAMIDES; INTERMEDIATE PRODUCTS
ES2007786A6 (es) Metodo para la fabricacion de 2,2', 4,4', 6,6'-hexanitrostilbeno (hns).
YU242887A (en) Process for producing mainly waterless crystalline cephadroxile
DE3580165D1 (de) Verfahren zur herstellung reiner dialkylsuccinate.
Farmer et al. Diffusional decomposition of c-ZrO 2 in Mg-PSZ
IL60889A0 (en) Insulin crystal supsension and process for the preparation thereof
JPS5246398A (en) Method for continuous production of beta-sic
JPS5534115A (en) Crystallization method
ATE53011T1 (de) Herstellung von chlorothalonyl.
JPS5618592A (en) Novel antibiotic, m5070 and its preparation
JPS5413477A (en) Continuous growing apparatus for single crystal
EP0293244A3 (en) N epsilon-trifluoroacetyl-l-lysyl-l-proline.d-1o-camphorsulfonic acid salt and process for producing the same
UA15830C2 (uk) Спосіб одержаhhя кристалічhого карбаміда
JPS5211193A (en) Production of crystalline gypsum fiber
JPS52133085A (en) Production of single silicon crystal of high purity
DE3663263D1 (en) Process for the production of tubes for use at temperatures up to minus 40 degrees celsius
JPS53119789A (en) Electric furnace for crystal growth
GB1393336A (en) Purification of beta-napthol by extractive crystallization
JPS5352682A (en) Purification of l-methionase
JPS54157796A (en) High purity mordenite type crystalline zeolite production
JPS549173A (en) Method of producing single crystal